AI assistant
Sending…
Health Catalyst, Inc. — Director's Dealing 2019
Jul 30, 2019
33681_dirs_2019-07-29_dcc29cf0-0c08-4537-a002-525a06eceaa3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-29
Reporting Person: Pramoda Anita (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-29 | Common Stock | C | 94348 | — | Acquired | 94348 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-29 | Series E Preferred Stock | $ | C | 94348 | Disposed | Common Stock (94348.0) | Indirect |
Footnotes
F1: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
F2: The shares are held by Omkara, LLC and the Reporting Person wholly-owns and holds the voting and dispositive power of these shares.
More from Health Catalyst, Inc.
M&A Activity
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 3
Interim / Quarterly Report
2026
May 11
Board/Management Information
2026
Apr 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27